DSIP
Delta Wave Sleep Architecture & Stress-Protective Neuropeptide
DSIP — Delta Sleep-Inducing Peptide
Last reviewed: August 2026
DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide discovered in 1977 that promotes deep, slow-wave (delta) sleep. Researchers studied it in human clinical trials for insomnia and chronic pain, with a favorable safety profile.
DSIP modulates GABAergic neurotransmission in the thalamus to promote delta wave sleep, reduces stress hormones (CRH and cortisol) that interfere with sleep, and provides antioxidant protection in the brain.
Chronic sleep deprivation is linked to Alzheimer's disease, metabolic syndrome, and cardiovascular disease. Most sleep aids suppress deep sleep rather than enhancing it. DSIP promotes delta wave sleep while reducing stress hormones.
DSIP is a neuropeptide that promotes deep sleep through GABAergic and HPA axis modulation, with human clinical trial data supporting its safety for insomnia research.
What is DSIP?
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first isolated from rabbit cerebral venous blood in 1977. It is a nonapeptide (9 amino acids) that modulates sleep architecture, specifically promoting delta (slow-wave) sleep. Beyond sleep, DSIP has demonstrated stress-protective, antioxidant, and neuroendocrine-modulating properties in preclinical and early clinical research.
- DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from rabbit cerebral venous blood by Marcel Monnier in 1977 during slow-wave sleep.
- Proposed mechanism: modulates GABA-B receptors and reduces somatostatin release, potentially facilitating the transition to delta (slow-wave) sleep by reducing cortical arousal.
- Endogenous DSIP is found in the hypothalamus, limbic system, and pituitary; plasma levels show circadian variation with peaks during sleep, suggesting a role in sleep-wake cycle regulation.
- Research has also examined DSIP's effects on stress response, cortisol regulation, and pain modulation — effects that extend beyond sleep induction to broader neuroendocrine regulation.
- The research base for DSIP is primarily from the 1980s–1990s; methodological limitations in early studies mean the mechanism remains incompletely characterized compared to more recently studied peptides.
Molecular Composition
DSIP is a 9-amino-acid nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) with a molecular weight of 848.9 Da. Its small size allows it to cross the blood-brain barrier, enabling direct central nervous system activity. It is naturally produced in the hypothalamus and released into the portal blood.
How Does It Work?
DSIP promotes restorative sleep by modulating GABAergic neurotransmission in the thalamus and normalizing cortisol rhythms, reducing the stress-driven sleep disruption.
DSIP modulates GABAergic neurotransmission in the thalamus and cortex, promoting the transition to slow-wave (delta) sleep. It also reduces corticotropin-releasing hormone (CRH) secretion and normalizes cortisol rhythms, providing stress-protective effects. Additionally, it scavenges reactive oxygen species and upregulates endogenous antioxidant enzymes.
Key Research Pathways
Delta Wave Induction / GABA Modulation
Modulates GABAergic neurotransmission in the thalamus and cortex, promoting the transition to slow-wave (delta) sleep and increasing sleep depth and duration.
HPA Axis Modulation
Reduces corticotropin-releasing hormone (CRH) secretion and normalizes cortisol rhythms, providing stress-protective effects and improving sleep quality in stress-induced insomnia models.
Antioxidant / Neuroprotective Activity
Scavenges reactive oxygen species and upregulates endogenous antioxidant enzymes, providing neuroprotective effects in oxidative stress models.
Key Findings from the Literature
- First isolated from rabbit cerebral venous blood by Monnier et al. (1977)
- Promotes delta wave (slow-wave) sleep through GABAergic modulation in the thalamus
- Reduces CRH and cortisol secretion, providing stress-protective effects
- Crosses the blood-brain barrier due to small molecular size (848.9 Da)
- Studied in human clinical trials for insomnia, chronic pain, and opiate withdrawal
Important Research Context
Research References
Peer-reviewed literature supporting the research profile of DSIP
The following peer-reviewed studies form the primary evidence base for DSIP's research profile. All references are sourced from PubMed, NCBI, and peer-reviewed scientific journals. Published research is available through PubMed, NCBI, and peer-reviewed biomedical journals.
- 1.
Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram (-sleep)-inducing peptide. Proceedings of the National Academy of Sciences USA. 1977.PMID: 265572
Original characterization of DSIP as a sleep-inducing peptide isolated from rabbit cerebral venous blood.
- 2.
Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle. Journal of Neurochemistry. 2006.PMID: 16539679
Review of DSIP's complex and context-dependent effects on sleep architecture and stress response.
- 3.
Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review. Neuroscience & Biobehavioral Reviews. 1984.PMID: 6145137
Comprehensive review of DSIP's role in sleep regulation, stress adaptation, and neuroendocrine function.
- 4.
Schoenenberger GA, Maier PF, Tobler HJ, Monnier M. A naturally occurring delta-EEG enhancing nonapeptide in rabbits. Pflügers Archiv. 1977.PMID: 560681
Discovery and characterization of DSIP's sleep-inducing properties in experimental models.
DSIP
Cognitive Research
Purgo Labs list price, read 12 Sep 2026 · per-lot COA on the vendor page
10mg $35.99 → $28.79 with code HEALTH (20% off; price read 23 Sept 2026)
- 1 certificate verified at the lab10mg$44.99$35.99→ $28.79
- 2 certificates verified at the lab10mg$55.00$38.00→ $34.20
- 1 certificate verified at the lab10mg$58.00→ $52.20
Fast FedEx shipping · Discreet packaging
Technical Specifications
| Peptide Class | Neuropeptide (9 amino acids) |
| Molecular Weight | 848.9 Da |
| Regulatory Status | Research chemical; no clinical approval |
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu |
| Available Sizes | 2mg, 5mg vials |
| Form | Lyophilized powder |
| Purity | ≥99% (third-party tested) |
View full legal status guide →
Source DSIP at Purgo Labs
10mg $35.99 list · $28.79 with code HEALTH · lab-verifiable COA per lot
Other Compounds in This Guide
Supporting Research
DSIP (Delta Sleep-Inducing Peptide) has only small, dated human studies from the 1970s-1990s with no modern replication. The evidence base is insufficient to support clinical claims.
References
- Schoenenberger GA, Monnier M.PRECLINICAL — original characterizationProceedings of the National Academy of Sciences USA. 1977. PubMedOriginal characterization of DSIP's sleep-inducing properties; foundational but dated and not replicated by modern standards.
- Kovalzon VM, Strekalova TV.REVIEWJournal of Neurochemistry. 2006. PubMedReview of DSIP literature noting inconsistent results and lack of modern replication; evidence base described as insufficient.
Research Databases
Ready to Source DSIP?
Purgo Labs offers DSIP with ≥99% purity, third-party certificates of analysis, and fast FedEx shipping. This is an affiliate link — we may earn a commission at no cost to you.